製藥 4.0 市場規模、佔有率和趨勢分析報告：2024-2030 年按類型、技術、最終用途、地區和細分市場進行的預測

Pharma 4.0 Market Size, Share & Trends Analysis Report By Type (Software, Services), By Technology (AI/ML, Big Data Analytics, IoT, Blockchain Technology), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日期: 2024年07月31日 | 出版商:

Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

製藥 4.0 市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球醫藥4.0市場規模將達到357.9億美元，2024年至2030年複合年成長率為18.96%。

製藥 4.0 市場由幾個關鍵因素推動，包括對個人化醫療的需求不斷成長、對提高效率和降低成本的需求、供應鏈最佳化以及對以患者為中心的方法的日益關注。慢性病和罕見疾病的盛行率不斷上升，增加了對個人化醫療的需求。積層製造（3D 列印）和模組化生產設備等製藥 4.0 技術透過實現個人化藥品和小批量生產以滿足患者個別需求，正在推動這一趨勢。

此外，數位技術的不斷採用也促進了市場的成長。這些技術最佳化、改進和轉變藥物開發、製造、分銷和患者照護。區塊鏈技術透過提供透明度、可追溯性和最佳化、減少缺貨、防止假冒以及提高整體效率和病患安全，正在大幅重新構想供應鏈管理。

此外，製藥公司對採用 Pharma 4.0 技術的投資增加也推動了市場成長。例如，Astra Zeneca簽署了一份價值高達8.4億美元的契約，用於罕見神經退化性疾病和神經肌肉疾病的靶點識別。作為協議的一部分，Astra Zeneca的 Alexion 部門將與 Verge Genomics 合作，確定這些疾病的藥物標靶。在這項為期四年的多目標協議中，兩家公司將使用機器學習來分析 Verge 的基因組資料集，這些資料集來自人體組織而不是細胞或動物模型。

製藥 4.0 市場報告亮點

按產品類型分類，由於效率提高、合規性提高和生產力提高等各種優勢，軟體的採用率不斷提高，因此軟體細分市場將在 2023 年佔據市場主導地位。此外，支援物聯網的軟體有助於即時監控和追蹤製造流程，從而實現更好的製程控制並減少停機時間。
從技術角度來看，由於人工智慧採用的擴大和投資的增加，人工智慧和機器學習領域佔據了最大的市場佔有率。例如，一項調查發現，超過 75% 的製藥高管計劃在 2025 年應用人工智慧來加速藥物發現。
從應用來看，由於藥物新興企業對人工智慧的投資增加，藥物發現和市場開拓在 2023 年佔據市場主導地位。
2023年，製藥和生物技術領域佔最大的市場佔有率，達到49.8%。製藥公司擴大採用 Pharma 4.0 技術，以提高製造流程的效率、生產力和質量，這推動了該領域的成長。
2023年，北美地區以41.12%的收益佔有率主導全球市場。這一成長歸功於政府主導的加強、醫療保健行業的技術進步以及主要市場參與者的強大影響力。

The global pharma 4.0 market size is expected to reach USD 35.79 billion by 2030, registering a CAGR of 18.96% from 2024 to 2030, according to a new report by Grand View Research, Inc. The pharma 4.0 market is being driven by several key factors, including the rising demand for personalized medicine, the need for improved efficiency and cost reduction, supply chain optimization, and an increasing focus on patient-centric approaches. The growing prevalence of chronic disorders and rare diseases has heightened the demand for personalized medicine. Pharma 4.0 technologies, such as additive manufacturing (3D printing) and modular production facilities, enable the production of personalized medicines and small batches tailored to individual patient needs, supporting this trend.

In addition, increasing adoption of digital technologies is driving the market growth. These technologies optimize, improve, and revolutionize drug development, manufacturing, distribution, and patient care. Blockchain technology has significantly reshaped supply chain management by offering transparency, traceability, and optimization, reducing stockouts, preventing counterfeiting, and enhancing overall efficiency and patient safety.

Furthermore, the market growth is being driven by increasing investments from pharmaceutical companies in adopting Pharma 4.0 technologies. For example, AstraZeneca signed a deal worth up to USD 840 million for the target identification of rare neurodegenerative and neuromuscular diseases. As part of this deal, AstraZeneca's Alexion division will collaborate with Verge Genomics to identify drug targets for these conditions. Over the course of the four-year, multi-target agreement, the companies will utilize machine learning to analyze Verge's genomic datasets, which are derived from human tissue rather than cell or animal models.

Pharma 4. 0 Market Report Highlights:

On the basis of type, the software segment dominated the market in 2023, owing to the increasing adoption of software due to various benefits such as efficiency enhancement, improved compliance and productivity. In addition, the IoT enabled software help in real time monitoring and tracking of manufacturing process, leading to better process control and reduces the downtime
On the basis of technology, the AI & ML segment held the largest market share owing to growing adoption of AI and increasing investments. For instance, as per a survey, over 75% of pharma executives plan to apply AI to speed drug discovery by 2025
On the basis of application, the drug discovery & development dominated the market in 2023 due to increased investment in AI for drug discovery startups
Pharma & biotech segment held the largest market share of 49.8% in 2023. Pharmaceutical companies are increasingly adopting Pharma 4.0 technologies to enhance efficiency, productivity, and quality in their manufacturing processes thereby driving the segment growth
North America dominated the global market with a revenue share of 41.12% in 2023. The growth is attributed to the increasing government initiative, technological advancement in the healthcare industry, and a strong presence of key market players

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. Technology
- 1.1.3. Application
- 1.1.4. End Use
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database.
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Pharma 4.0 Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
3.3. Pharma 4.0 Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape
- 3.3.3. COVID-19 Impact

Chapter 4. Pharma 4.0 Market: Type Estimates & Trend Analysis

4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Pharma 4.0 Market by Type Outlook
4.4. Software
- 4.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)
4.5. Services
- 4.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 5. Pharma 4.0 Market: Technology Estimates & Trend Analysis

5.1. Technology Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Pharma 4.0 Market by Technology Outlook
5.4. AI & ML
- 5.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)
5.5. Big Data Analytics
- 5.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)
5.6. IoT
- 5.6.1. Market estimates and forecast 2018 to 2030 (USD Billion)
5.7. Block chain Technology
- 5.7.1. Market estimates and forecast 2018 to 2030 (USD Billion)
5.8. Others (Digital twin, Advanced robotics, AR &VR)
- 5.8.1. Market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 6. Pharma 4.0 Market: Application Estimates & Trend Analysis

6.1. Application Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Pharma 4.0 Market by Application Outlook
6.4. Drug Discovery & Development
- 6.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)
6.5. Manufacturing
- 6.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)
6.6. Supply Chain Management
- 6.6.1. Market estimates and forecast 2018 to 2030 (USD Billion)
6.7. Others (Product Lifecycle Management, Personalized Medicine, Regulatory Compliance)
- 6.7.1. Market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 7. Pharma 4.0 Market: End Use Estimates & Trend Analysis

7.1. End Use Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Pharma 4.0 Market by End Use Outlook
7.4. Pharma & Biotech companies
- 7.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)
7.5. Healthcare Providers
- 7.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)
7.6. CRO & CDMO
- 7.6.1. Market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 8. Pharma 4.0 Market: Regional Estimates & Trend Analysis, By type, By technology, By Application, By End Use

8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
8.5. North America
- 8.5.1. U.S.
  - 8.5.1.1. Key country dynamics
  - 8.5.1.2. Regulatory framework/ reimbursement structure
  - 8.5.1.3. Competitive scenario
  - 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.5.2. Canada
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Regulatory framework/ reimbursement structure
  - 8.5.2.3. Competitive scenario
  - 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.5.3. Mexico
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Regulatory framework/ reimbursement structure
  - 8.5.3.3. Competitive scenario
  - 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)
8.6. Europe
- 8.6.1. UK
  - 8.6.1.1. Key country dynamics
  - 8.6.1.2. Regulatory framework/ reimbursement structure
  - 8.6.1.3. Competitive scenario
  - 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.6.2. Germany
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Regulatory framework/ reimbursement structure
  - 8.6.2.3. Competitive scenario
  - 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.6.3. France
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Regulatory framework/ reimbursement structure
  - 8.6.3.3. Competitive scenario
  - 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.6.4. Italy
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. Regulatory framework/ reimbursement structure
  - 8.6.4.3. Competitive scenario
  - 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.6.5. Spain
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. Regulatory framework/ reimbursement structure
  - 8.6.5.3. Competitive scenario
  - 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.6.6. Norway
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Regulatory framework/ reimbursement structure
  - 8.6.6.3. Competitive scenario
  - 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.6.7. Sweden
  - 8.6.7.1. Key country dynamics
  - 8.6.7.2. Regulatory framework/ reimbursement structure
  - 8.6.7.3. Competitive scenario
  - 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.6.8. Denmark
  - 8.6.8.1. Key country dynamics
  - 8.6.8.2. Regulatory framework/ reimbursement structure
  - 8.6.8.3. Competitive scenario
  - 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
8.7. Asia Pacific
- 8.7.1. Japan
  - 8.7.1.1. Key country dynamics
  - 8.7.1.2. Regulatory framework/ reimbursement structure
  - 8.7.1.3. Competitive scenario
  - 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.7.2. China
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Regulatory framework/ reimbursement structure
  - 8.7.2.3. Competitive scenario
  - 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.7.3. India
  - 8.7.3.1. Key country dynamics
  - 8.7.3.2. Regulatory framework/ reimbursement structure
  - 8.7.3.3. Competitive scenario
  - 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.7.4. Australia
  - 8.7.4.1. Key country dynamics
  - 8.7.4.2. Regulatory framework/ reimbursement structure
  - 8.7.4.3. Competitive scenario
  - 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.7.5. South Korea
  - 8.7.5.1. Key country dynamics
  - 8.7.5.2. Regulatory framework/ reimbursement structure
  - 8.7.5.3. Competitive scenario
  - 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.7.6. Thailand
  - 8.7.6.1. Key country dynamics
  - 8.7.6.2. Regulatory framework/ reimbursement structure
  - 8.7.6.3. Competitive scenario
  - 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
8.8. Latin America
- 8.8.1. Brazil
  - 8.8.1.1. Key country dynamics
  - 8.8.1.2. Regulatory framework/ reimbursement structure
  - 8.8.1.3. Competitive scenario
  - 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.8.2. Argentina
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. Regulatory framework/ reimbursement structure
  - 8.8.2.3. Competitive scenario
  - 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
8.9. MEA
- 8.9.1. South Africa
  - 8.9.1.1. Key country dynamics
  - 8.9.1.2. Regulatory framework/ reimbursement structure
  - 8.9.1.3. Competitive scenario
  - 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.9.2. Saudi Arabia
  - 8.9.2.1. Key country dynamics
  - 8.9.2.2. Regulatory framework/ reimbursement structure
  - 8.9.2.3. Competitive scenario
  - 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.9.3. UAE
  - 8.9.3.1. Key country dynamics
  - 8.9.3.2. Regulatory framework/ reimbursement structure
  - 8.9.3.3. Competitive scenario
  - 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
- 8.9.4. Kuwait
  - 8.9.4.1. Key country dynamics
  - 8.9.4.2. Regulatory framework/ reimbursement structure
  - 8.9.4.3. Competitive scenario
  - 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Key company market share analysis, 2023
9.4. Company Profiles
- 9.4.1. Microsoft Corporation
  - 9.4.1.1. Company overview
  - 9.4.1.2. Financial performance
  - 9.4.1.3. Product benchmarking
  - 9.4.1.4. Strategic initiatives
- 9.4.2. IBM
  - 9.4.2.1. Company overview
  - 9.4.2.2. Financial performance
  - 9.4.2.3. Product benchmarking
  - 9.4.2.4. Strategic initiatives
- 9.4.3. Amazon Web Service (AWS)
  - 9.4.3.1. Company overview
  - 9.4.3.2. Financial performance
  - 9.4.3.3. Product benchmarking
  - 9.4.3.4. Strategic initiatives
- 9.4.4. SAP
  - 9.4.4.1. Company overview
  - 9.4.4.2. Financial performance
  - 9.4.4.3. Product benchmarking
  - 9.4.4.4. Strategic initiatives
- 9.4.5. Oracle
  - 9.4.5.1. Company overview
  - 9.4.5.2. Financial performance
  - 9.4.5.3. Product benchmarking
  - 9.4.5.4. Strategic initiatives
- 9.4.6. GE Healthcare
  - 9.4.6.1. Company overview
  - 9.4.6.2. Financial performance
  - 9.4.6.3. Product benchmarking
  - 9.4.6.4. Strategic initiatives
- 9.4.7. Siemens Healthineers
  - 9.4.7.1. Company overview
  - 9.4.7.2. Financial performance
  - 9.4.7.3. Product benchmarking
  - 9.4.7.4. Strategic initiatives
- 9.4.8. Cisco
  - 9.4.8.1. Company overview
  - 9.4.8.2. Financial performance
  - 9.4.8.3. Product benchmarking
  - 9.4.8.4. Strategic initiatives
- 9.4.9. Cinntra
  - 9.4.9.1. Company overview
  - 9.4.9.2. Financial performance
  - 9.4.9.3. Product benchmarking
  - 9.4.9.4. Strategic initiatives
- 9.4.10. Dassault Systems
  - 9.4.10.1. Company overview
  - 9.4.10.2. Financial performance
  - 9.4.10.3. Product benchmarking
  - 9.4.10.4. Strategic initiatives
- 9.4.11. Nexocode
  - 9.4.11.1. Company overview
  - 9.4.11.2. Financial performance
  - 9.4.11.3. Product benchmarking
  - 9.4.11.4. Strategic initiatives

簡介目錄圖表

List of Tables

Table 1 List of abbreviation
Table 2 North America Pharma 4.0 Market, by region, 2018 - 2030 (USD Million)
Table 3 North America Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 4 North America Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 5 North America Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 6 North America Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 7 U.S. Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 8 U.S. Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 9 U.S. Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 10 U.S. Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 11 Canada Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 12 Canada Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 13 Canada Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 14 Canada Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 15 Mexico Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 16 Mexico Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 17 Mexico Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 18 Mexico Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe Pharma 4.0 Market, by region, 2018 - 2030 (USD Million)
Table 20 Europe Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 21 Europe Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 22 Europe Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 23 Europe Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 24 Germany Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 25 Germany Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 26 Germany Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 27 Germany Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 28 UK Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 29 UK Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 30 UK Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 31 UK Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 32 France Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 33 France Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 34 France Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 35 France Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 36 Italy Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 37 Italy Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 38 Italy Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 39 Italy Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 40 Spain Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 41 Spain Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 42 Spain Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 43 Spain Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 44 Denmark Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 45 Denmark Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 46 Denmark Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 47 Denmark Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 48 Sweden Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 49 Sweden Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 50 Sweden Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 51 Sweden Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 52 Norway Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 53 Norway Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 54 Norway Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 55 Norway Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 56 Asia Pacific Pharma 4.0 Market, by region, 2018 - 2030 (USD Million)
Table 57 Asia Pacific Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 61 China Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 62 China Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 63 China Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 64 China Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 65 Japan Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 66 Japan Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 67 Japan Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 68 Japan Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 69 India Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 70 India Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 71 India Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 72 India Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 73 South Korea Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 74 South Korea Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 75 South Korea Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 76 South Korea Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 77 Australia Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 78 Australia Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 79 Australia Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 80 Australia Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 81 Thailand Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 82 Thailand Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 83 Thailand Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 84 Thailand Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 85 Latin America Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 86 Latin America Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 87 Latin America Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 88 Latin America Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 89 Brazil Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 90 Brazil Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 91 Brazil Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 92 Brazil Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 93 Argentina Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 94 Argentina Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 95 Argentina Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 96 Argentina Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 97 MEA Pharma 4.0 Market, by region, 2018 - 2030 (USD Million)
Table 98 MEA Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 99 MEA Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 100 MEA Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 101 MEA Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 102 South Africa Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 103 South Africa Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 104 South Africa Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 105 South Africa Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 106 Saudi Arabia Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 110 UAE Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 111 UAE Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 112 UAE Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 113 UAE Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
Table 114 Kuwait Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
Table 115 Kuwait Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
Table 116 Kuwait Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
Table 117 Kuwait Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)